A Study to See if Clinical Cardiac MRI Scanning Can Cause DNA Damage


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-002496
    Sponsor Protocol Number: 16-002496

About this study

The long-term goal of this research program is to clarify the potential mutation causing and cancer causing risk posed by clinical magnetic resonance imaging (MRI).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria

  • Adults, >18 years
  • Scheduled to undergo any elective cardiac MR, cardiac CT, or echocardiogram exam at Mayo

Exclusion Criteria

  • History of malignancy
  • Received radiation therapy or chemotherapy immediately prior to exam
  • Had immunosuppressant drugs at the time of their exam
  • Underwent any MR or CT  within 7 days prior to their exam

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jennifer McDonald, Ph.D.

Closed for enrollment

Contact information:

Cindy Fitting




Mayo Clinic Footer